Friday Apr 18
Update on Colchicine
Manouchkathe Cassagnol, PharmD, CGP, BCPS Associate Clinical Professor Department of Clinical Pharmacy Practice St. John's University College of Pharmacy and Health Sciences Clinical Coordinator of Cardiovascular Pharmacotherapy Long Island Jewish Medical Center Nicole M. Maisch, PharmD Associate Clinical Professor Department of Clinical Pharmacy ... (more)
Thu Apr 10, 2014
Treatments that suppressed Jim Flaherty's rare skin disorder had a tremendous effect on him
Upon hearing of the death of former finance minister Jim Flaherty, doctors expressed worry about the side-effects that treatments for his rare skin disorder do "to the body and mind."
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued...
"This patent allowance by the USPTO is another important milestone in achieving our goal of protecting the innovation and commercial potential of RAYOS," stated Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma.
Wed Apr 09, 2014
Bayer Initiates Phase 3 Trial of Xofigo radium Ra 223...
The randomized, double-blind, placebo-controlled Phase 3 trial is designed to determine the effects of this combination treatment on symptomatic skeletal event-free survival .
Sun Apr 06, 2014
Early diagnosis important to treat Wegener's
Dear Dr. Roach: In March 2009, a family member was hav ing terrible flu-like symptoms accompanied by horrific headaches.
Sat Apr 05, 2014
Will bronchial thermoplasty for asthma be more widely used?
I first met Carol* when she came to my clinic after a severe asthma attack had sent her to the intensive care unit.
Fri Apr 04, 2014
cancer and my dog: all treat day
First of all, I would like to thank all of you who have commented with suggestions, supports of love, and for just caring about some one you have never met.
Thu Apr 03, 2014
Radium-223 dichloride in prostate cancer: Major added benefit for certain patients
Radium-223 dichloride has been approved since November 2013 for men with advanced prostate cancer, in whom hormone blockade is no longer effective, and symptomatic bone metastases, but without visceral metastases.
Wed Apr 02, 2014
Bayer Initiates Phase 3 Trial of XofigoA (radium Ra 223 dichloride)...
Bayer Initiates Phase 3 Trial of XofigoA Injection in Combination with Abiraterone Acetate for Asymptomatic or Mildly Symptomatic Chemotherapy-Naive Patients with Bone Predominant Metastatic Castration-Resistant Prostate Cancer /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced that the company has begun to enroll patients in a ... (more)
Wed Mar 26, 2014
Disappointment Over Prostate Cancer Drug Study Weigh Heavily on Exelixis
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
Tue Mar 25, 2014
Customer Interaction Solutions
Exelixis Provides Update on Ongoing COMET-1 Phase 3 Pivotal Trial in...
Exelixis, Inc. announced that the Independent Data Monitoring Committee notified the company today that a planned interim analysis of the COMET-1 phase 3 pivotal trial has been completed, and that the IDMC recommended the trial proceed to its final analysis.
People's Pharmacy: Readers offer help for horrible hives
Hives are red, itchy bumps on the skin. They often are caused by an allergic reaction that lasts for a few hours or a couple of days.
Mon Mar 24, 2014